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INTRODUCTION
Since 2004 a significant proportion of 
income for UK primary care has come from 
pay-for-performance quality-improvement 
schemes such as the Quality and Outcomes 
Framework (QOF).1 –4 Their effectiveness in 
providing large-scale quality improvement 
has been questionable, with a Cochrane 
Review in 2011 concluding that there was 
not enough evidence to either support using 
or not using such schemes.5 Finding a 
meaningful control group for comparison 
of national schemes is often impossible, 
and though time-series analysis did appear 
to show a small initial acceleration in 
improvement of certain standards after the 
introduction of QOF, this was short lived.6–8 
Negative effects on quality have also been 
reported relating to a lack of a holistic 
approach, reduced patient-centredness, 
and time away from clinical care to complete 
paperwork.5,8–13 
Alternative quality-improvement 
methods have been suggested that both 
focus on local health needs and avoid 
pay-for-performance measures.1,12,14–16 
This study aimed to measure the effects 
of one such intervention used across 
East Lancashire, where recorded rates 
of atrial fibrillation (AF) and hypertension 
were lower than expected,17 which funded 
surgeries to design and reflect on their 
own quality-improvement programmes for 
these conditions, tailored to local needs.
METHOD
Study design and setting
The authors conducted a controlled before–
after study looking at the effects on patients 
of a quality-improvement intervention that 
aimed to improve diagnosis and management 
of AF and hypertension within the intervention 
group, which consisted of all surgeries in East 
Lancashire Clinical Commissioning Group 
(CCG) compared to a control group, which 
consisted of all other surgeries in north-west 
England. Both groups continued to participate 
in, and provide data through QOF. The authors 
excluded two out of 1174 (0.17%) surgeries 
for which published data existed at baseline 
– both newly opened control surgeries as they 
either did not have any patients registered 
with AF or hypertension, or had a list size of 
<10 patients. All surgeries in East Lancashire 
CCG participated in the intervention, which is 
described in Box 1.17 Representatives from 
each surgery attended 3-monthly quality —
improvement workshops for the first year, 
aimed at sharing ideas about best practice. 
Reminders on surgeries’ clinical systems 
were allowed in both groups, which are mainly 
triggered by absent QOF indicators such as 
no recent CHA2DS2-VASc, no recent blood 
pressure (BP) reading, or decision needed 
on whether to anticoagulate. Additional 
prompts for relevant non-QOF indicators such 
as checking pulse rhythm in patients aged 
≥65 years were promoted during workshops 
for surgeries in the intervention group but 
remained optional. 
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Abstract
Background
Financial incentives in the UK such as the Quality 
and Outcomes Framework (QOF) reward GP 
surgeries for achievement of nationally defined 
targets. These have shown mixed results, with 
weak evidence for some measures, but also 
possible unintended negative effects. 
Aim
To look at the effects of a local intervention for 
atrial fibrillation (AF) and hypertension, with 
surgeries rewarded financially for work, including 
appointing designated practice leads, attendance 
at peer review workshops, and producing their 
own protocols. 
Design and setting
A controlled before–after study comparing surgery 
performance measures in UK primary care.
Method
This study used published QOF data to analyse 
changes from baseline in mean scores per 
surgery relating to AF and hypertension 
prevalence and management at T1 (12 months) 
and T2 (24 months) for the intervention group, 
which consisted of surgeries in East Lancashire 
Clinical Commissioning Group (CCG), compared 
to the control group, which consisted of all 58 
surgeries in north-west England. 
Results
There was a small acceleration between T0 
(baseline) and T2 in recorded prevalence of 
hypertension in the intervention group compared 
to the controls, difference 0.29% (95% confidence 
interval [CI] = 0.05 to 0.53), P = 0.017, but 
AF prevalence did not increase more in the 
intervention group. Improvement in quality of 
management of AF was significantly better in the 
intervention group, difference 3.24% (95% CI = 1.37 
to 5.12), P = 0.001. 
Conclusion
This intervention improved diagnosis rates of 
hypertension but not AF, though it did improve 
quality of AF management. It indicates that funded 
time to develop quality-improvement measures 
targeted at a local population and involving peer 
support can engage staff and have the potential to 
improve quality. 
Keywords
atrial fibrillation; hypertension; physician incentive 
plans; primary health care; quality improvement. 
Outcome measures
Outcome measures are summarised in Table 
1. Data are available for the end of each QOF 
year (31 March)18–20 at surgery and CCG level. 
These were obtained for 31 March 2016 (T0 — 
the day before intervention started), 31 March 
2017 (T1 [12 months]), and 31 March 2018 
(T2 [24 months]) for all surgeries in north-
west England. CCG-wide prevalence data 
were also obtained for QOF years before the 
intervention: 31 March 2013 (T–3), 31 March 
2014 (T–2), and 31 March 2015 (T–1) to allow 
time-series analyses. All patients excepted 
for QOF data (unsuitable, no consent to 
investigate, or treat) were included in all 
outcome measures to prevent bias arising 
from different surgery policies on excepting 
patients.
The primary outcome measures looked 
at two improved rates of diagnosis. These 
were the change in mean prevalence of 
AF; and the change in mean prevalence 
of hypertension, at T1 and T2 compared 
to baseline. Secondary outcome measures 
looked at quality of management of AF and 
hypertension, and in assessing patients 
at risk of hypertension. The QOF indicator 
DQAF1 combined the two QOF measures 
that look at subgroups of patients with AF, in 
order to assess the quality of management 
across the whole AF population.
Statistical analysis
Primary analysis included patient data from 
all surgeries in north-west England, based on 
the practice code to avoid loss of data owing 
to renamed surgeries. Surgeries with no data 
How this fits in
Over the last ten years new quality-
improvement interventions such as 
the NHS health check have struggled 
to engage UK general practice. This 
study shows that facilitating a locally 
designed intervention tailored to the 
needs of the local population, without 
the burden of targets, may lead to higher 
levels of engagement by GP surgeries. 
Previous studies looking at quality-
improvement interventions for diagnosis 
and management of atrial fibrillation (AF) 
and hypertension have been mixed in 
their findings, and interpretation has been 
difficult owing to limitations of time-series 
analyses or controls based in different 
healthcare systems. This study compares 
results with a local control group and 
demonstrates a statistically significantly 
higher increase in diagnosis rates of 
hypertension but not AF. Improvement in 
quality of management of AF showed a 
statistically significantly higher increase, 
though this was not demonstrated for 
control of hypertension.
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Box 1. Intervention — agreed standards and required outcomes of family practices for improvement in 
management and diagnosis of patients with atrial fibrillation and hypertension
Clinical area (remuneration) Agreed standards Required outcomes
Atrial fibrillation
(0.35 GBP per weighted head • To implement a robust protocol for the identification, • Names of the clinical and administrative leads responsible for AF  
    management 
of total population on books)  diagnosis, and appropriate management of people with AF • Number of patients recorded as having AF on computer records 
 • Review benchmarked data • Number of patients aged ≥65 years not already diagnosed with 
 • All patients aged ≥65 years, not already with a diagnosis of  AF with a recording of pulse, both rate and rhythm, in the last 
  AF, to have pulse, rate, and rhythm recorded  12 months 
 • Ensure that all patients found to have an irregular pulse are • Number of patients found to have an irregular pulse who have 
  offered a 12-lead ECG  been offered a 12-lead ECG
 • Ensure patients are offered an explanation as to why their • Percentage of patients recorded having been told why their rate  
  pulse, rate, and rhythm, are checked  and rhythm is checked regularly 
   • Number of patients referred to or offered anticoagulation 
    services as per QOF requirements
 
Hypertension
(0.25 GBP per weighted • To implement a robust protocol for the identification,  • Names of the clinical administrative leads responsible for 
head of population)  diagnosis and appropriate management of people with high  hypertension management 
  blood pressure • Number of patients recorded as having hypertension on 
 • Review benchmarked data  computer records
 • Increase detection of hypertension • Number of patients found to have BP >140/90 mmHg who have 
 • Ensure that all patients with a BP reading  been offered a 24-hour ambulatory or home BP monitoring 
  >140/90 mmHg have a 24-hour ambulatory or home BP • Number/percentage of people aged ≥40 years who have had 
  monitoring   their BP recorded in the last 5 years
AF = atrial fibrillation. ECG = electrocardiogram. BP = blood pressure. QOF = Quality Outcomes Framework.
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for outcome measures at T1 or T2 (surgery 
closed down, merged without maintaining 
practice code or opted out of QOF), were 
excluded from calculations relating to these 
time points. Independent t-tests were used 
to compare changes in the intervention group 
to those in the control group for all outcome 
measures. Time-series analyses provided 
further evaluation of changing prevalence 
rates by assessing the net annual changes in 
prevalence per CCG from T0 to T2 compared 
to before the intervention (T–3 to T0). SPSS 
(version 24) was used for all statistical 
analyses and Excel for graphs.
RESULTS
Flow of surgeries in the intervention and 
control groups is shown in Figure 1. The 
intervention commenced 1 April 2016 
with the workshops and local protocol 
design occurring in the first 12 months. 
Data were analysed for all 58 surgeries in 
the intervention group and all 1114 in the 
control group. Loss of follow up owing to 
closure, being amalgamated into a larger 
surgery, or opting out of QOF, was small 
with 1 (1.7%) surgery lost to follow up in 
1174 surgeries
assessed for eligibility
1172 suitable for
inclusion in study
58 surgeries in
East Lancashire
CCG, all
participating in
intervention
57 followed up at T1
(1 merged with larger practice)
57 followed up at T2
1081 followed up at T1
(27 closed/merged with larger practice
1 no data collected)
1053 followed up at T2
(58 closed/merged with larger practice
3 no data collected)
1114 surgeries in
remaining CCGs in
north-west England,
designated to control
group
Figure 1. Flow diagram showing participation and 
flow through the study. CCG = clinical commissioning 
group. T1 = 12 months from baseline time. 
T2 = 24 months from baseline time.
Table 1. Atrial fibrillation and hypertension outcome measures
 Outcome/ QOF  
Clinical group indicator code Numerator Denominator
Atrial fibrillation AF001 Patients recorded as having AF Whole population of surgery
 DQAF1 Patients with AF treated  Total number of patients with 
  successfully as per QOF indicators  AF within surgery (AF001)a 
  AF006 and AF007, by having a  
  previous CHA2DS2-VASc score  
  of ≥2 and being on anticoagulation,  
  or having an up-to-date  
  CHA2DS2-VASc score of <2 in the  
  past 12 months 
Hypertension HYP001 Patients recorded as having Whole population of surgery 
  hypertension
 HYP006 Patients with hypertension whose  Total number of patients with 
  BP is treated successfully to  hypertension within surgery 
  ≤150/90 mmHg in the past  (HYP001)b 
  12 months 
 BP002 Patients aged ≥45 years who have  Whole population of surgery 
  a recorded BP reading in the past  aged ≥45 yearsc 
  12 months 
aQOF data excludes patients newly (within the past 3 months) diagnosed or registered with the surgery. bQOF data 
excludes patients newly (within the past 9 months) diagnosed or registered with the surgery. cQOF data excludes 
patients newly (within the past 3 months) registered with the surgery. AF = atrial fibrillation. QOF = Quality Outcomes 
Framework. BP = blood pressure. 
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the intervention group and 33 (3.0%) lost to 
follow up in the control group. 
The Quality Outcomes Framework 
provides limited data relevant to disease 
populations from which baseline 
demographics can be taken. However, the 
data do show similar percentages in age/
sex groups recorded by QOF in the two study 
groups, and identical mean list size (Table 
2). Estimated actual disease prevalence 
data based on demographics such as age, 
sex, and deprivation indices, were also 
similar: disease prevalence 2.46% for the 
intervention group, compared to 2.47% for 
the control group for AF, and 23.88% and 
24.30% respectively for hypertension21,22 
(data not shown in Tables).
Table 3 shows the mean values for 
each outcome measure per surgery 
at T0 (baseline), T1 (12 months), and 
T2 (24 months) within the control and 
intervention groups, and compares the 
P-values for the change from baseline 
between the groups. From T0 to T2, mean 
hypertension prevalence in the intervention 
group increased from 13.80% to 14.35%, 
mean change per surgery 0.59%, and in the 
control group, it increased from 14.50% to 
14.74%, mean change 0.30%. This gives a 
difference between groups of 0.29% (95% 
confidence interval [CI] = 0.05 to 0.53), 
P = 0.017. Using Benjamini–Hochberg 
correction for multiple comparisons to 
assess significance of any changes at an 
individual time point (pk ≤ k/5 x 0.05), this 
remains statistically significant. Mean 
AF prevalence in the intervention group 
increased from 1.55% to 1.81%, mean 
change 0.26%, and in the control group, 
it increased from 1.77% to 1.99%, mean 
change 0.22%. This gives a statistically non-
significant mean change between groups of 
0.04% (95% CI = –0.03 to 0.12). 
There were no data available for the 
control group on pulse checks performed 
for people aged ≥65 years without known 
AF in the past year as it does not form 
part of QOF, and no baseline data for the 
intervention group. Analysis within the 
intervention group (for people ≥40 years 
as the local intervention targeted a slightly 
lower age range than QOF) at 15 months 
and 27 months respectively (the closest 
available to T1 and T2) showed improving 
standards with a mean rate per surgery 
of 37.67% (95% CI = 32.84 to 42.50) at 
15 months, and 45.85% (95% CI = 41.24 to 
50.46) at 27 months, an increase of 8.18% 
(95% CI = 1.57 to 14.80) over 12 months, 
P = 0.016. 
Time-series analyses for mean recorded 
prevalence of AF and hypertension per 
CCG are shown in Figure 2, comparing 
the 2 years since the study commenced to 
the 3 previous years. For hypertension, the 
annual rate of increase increased by 0.18% 
per year more in the intervention group 
than in the control group (95% CI = –0.25 
to 0.61), but this was statistically non-
Table 2. Baseline demographics
Characteristic Control group Intervention group
Practices
 Surgeries, n 1114 58
 CCGs, n 30 1
 Total registered patients, n 7 212 515 375 488
 Practice list size, mean n 6474 6474  
Patients  
 Females aged 25–64 years, n, (%)   1 869 553 (25.92) 96 214 (25.62)
  All aged <18 years, n, (%) 1 483 480 (20.57) 82 591 (22.00)
 All aged ≥50 years, n, % 2 641 058 (36.62) 138 751 (36.95)
CCG = clinical commissioning group. 
Table 3. Surgery-level summary of outcome measures determined from published QOF data before and 
12 months following introduction of intervention
 Control group mean % per surgerya (95% CI) Intervention group mean % per surgerya (95% CI)
Outcome measure 31 March 2016 (T0)  31 March 2017 (T1) 31 March 2018 (T2) 31 March 2016 (T0) 31 March 2017 (T1) 31 March 2018 (T2)
Atrial fibrillation
AF001  1.77 (1.72 to 1.82) 1.92 (1.86 to 1.98) 1.99 (1.94 to 2.04) 1.55 (1.42 to 1.68) 1.74b (1.60 to 1.88) 1.81c (1.67 to 1.96)
DQAF1 78.48 (78.01 to 78.95) 82.23 (81.82 to 82.63) 84.77 (84.39 to 85.16) 73.25 (71.29 to 75.22) 79.11d (77.29 to 80.93) 82.86e (81.19 to 84.53)
Hypertension
HYP001  14.50 (14.28 to 14.72) 14.65 (14.43 to 14.87) 14.74 (14.52 to 14.95) 13.80 (13.17 to 14.43) 14.05f (13.41 to 14.69) 14.35g (13.69 to 15.01)
HYP006  80.61 (80.29 to 80.93) 81.16 (80.85 to 81.48) 80.46 (80.13 to 80.78) 80.38 (78.53 to 82.23) 81.40h (79.83 to 82.97) 80.76i (79.08 to 82.44)
BP002  91.10 (90.92 to 91.28) 91.24 (91.06 to 91.41) 91.19 (91.01 to 91.36) 91.23 (90.54 to 91.91) 91.38j (90.71 to 92.05) 91.74k (91.03 to 92.44)
aGross percentages of means per surgery are calculated (without any patients excepted on clinical or consensual grounds). Statistical significance of differences in changes from T0 
for the intervention group compared to the control group is calculated using independent t-tests. bP = 0.051, cP = 0.31, dP = 0.01, eP = 0.001, fP = 0.21, gP= 0.017, hP = 0.37, iP= 0.32, 
jP= 0.75, kP = 0.03. AF = atrial fibrillation. T0 = baseline time. T1 = 12 months from baseline time. T2 = 24 months from baseline time. 
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significant (P = 0.40). The change in rate 
of annual increase of AF prevalence was 
very similar (0.02% per year higher in the 
intervention group). 
DQAF1, a marker of quality in 
management of patients recorded as 
having AF, showed a significant increase 
in the intervention group compared to the 
control group. In the intervention group, it 
increased from 73.25% at T0 to 82.86% at 
T2, mean change 9.58%, Table 3. The mean 
in the control group increased from 78.48% 
at T0 to 84.77% at T2, mean change 6.34%. 
This gives a mean change between groups 
of 3.24% (95% CI = 1.37 to 5.12), P = 0.001. 
The difference in BP002 at T2 compared 
to T0 was 0.55% in the intervention group 
and 0.10% in the control group, giving a 
mean change between groups of 0.45% 
(95% CI = 0.04 to 0.86), P = 0.03. These 
differences in the change from baseline 
remained statistically significant when 
correcting for multiple measures using 
the Benjamini–Hochberg correction. The 
mean change in HYP006 at T2 compared 
to T0 was 0.43% in the intervention group 
and –0.22% in the control group, giving a 
statistically non-significant mean change 
between groups of 0.65% (95% CI = –0.06 
to 1.93). 
At the same time as the presented 
intervention, there was a pharmacist-led 
scheme for patients in East Lancashire 
CCG with a diagnosis of AF who were taking 
direct oral anticoagulants (DOACs). In order 
to assess whether this might be the main 
driver behind improvements in DQAF1, the 
authors used study data (available for the 
intervention group only) on the proportion 
of patients with AF who were taking DOACs. 
Bivariate Pearson correlation found no 
statistically significant relationship between 
the change in DQAF1 and the proportion of 
patients taking DOACs (P = 0.22 at both T1 
and T2). 
DISCUSSION
Summary
In this controlled before–after study 
compared to the control group, there was 
a statistically significant increase in mean 
prevalence rate of hypertension but not AF 
in surgeries carrying out an intervention, 
which included appointing surgery 
leads for AF and hypertension, sending 
representatives to quarterly quality-
improvement workshops, and producing 
surgery protocols. Time-series analyses at 
CCG level looking at annual changes in 
recorded AF and hypertension prevalence 
before and during the intervention showed 
this was unlikely to be due to pre-existing 
trends differing between the two groups. 
The increase in percentage of patients 
diagnosed with AF who received optimal 
care and management relating to 
anticoagulation was statistically significantly 
larger in the intervention group. Local 
work outside of the intervention aimed at 
improving management of patients with 
AF taking DOACs did not seem to be the 
main driver behind this, though could have 
had an incremental effect as part of a 
multidisciplinary response. There was a 
small significant increase in the intervention 
group in the percentage of patients aged 
≥45 years with a BP check in the past 
5 years, though there were no significant 
differences in the change in quality of care 
for patients with hypertension, as measured 
by BP≤150/90 mmHg.
Strengths and limitations
This study eliminates selection bias when 
GP surgeries except patients — seen in all 
seven studies looked at by the Cochrane 
review5 — and provides a well-matched 
control group in the same timeframe and 
region as the intervention group, eliminating 
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Figure 2. Prevalence of AF and hypertension per CCG. 
AF = atrial fibrillation. CCG = clinical commissioning 
group. T–3 = 36 months before baseline. T–2 = 24 
months before baseline time. T–1 = 12 months before 
baseline time. T0 = baseline time. T1 = 12 months from 
baseline time. T2 = 24 months from baseline time. 
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potential bias seen in other studies.1,10,12 
Similarities in baseline measures and 
expected prevalence rates in the present 
intervention and control groups,21,22 provide 
confidence that the two groups are likely 
to be similar populations. Engagement in 
the intervention appeared good with 100% 
invited surgeries agreeing to take part, and 
nearly half of targeted patients per surgery 
receiving an annual pulse rhythm check, 
with significant improvements demonstrable 
between 15 and 27 months.
The main drawback of this study’s control 
group was that other CCGs may have 
run their own schemes on top of usual 
care, and measures of standards, such as 
rates of pulse checks, were unavailable 
from the control group. However, effects 
from a single CCG are minimised by the 
control group consisting of 30 CCGs. There 
is also risk of contamination from patients 
registering with a different surgery and so 
moving between groups, or away from the 
region completely. This effect is likely to be 
small as there is <2% annual change in 
numbers of patients registered within the 
intervention group, which closely follows the 
national trend for population growth, taking 
into account mortality rates of 0.97% in the 
intervention group and 0.92% in the control 
group.18-20,23 
Analysis of QOF data is limited by data 
being recorded only once a year, and it 
is possible that more data points would 
have demonstrated a short-lived significant 
benefit to AF prevalence rates, as the 
difference approached significance after 
12 months but was smaller by 24 months.
Comparison with existing literature
In recent years, new GP quality-improvement 
schemes have seen lower participation 
rates than QOF for example, the Learning 
Disabilities Health Check Scheme iwith 
65% uptake, and high variability between 
populations, for example, the NHS Health 
Check uptake per local authority ranging 
from 9.5%-53.0%. Reasons suggested for 
these include lack of resources, incentive 
size, and poor population engagement.24,25 
However, this study shows that if these 
can be overcome, there can still be high 
engagement.
The present finding that a primary 
care hypertension intervention can cause 
a statistically significant increase in 
recorded prevalence rates differs from the 
three previous primary care hypertension 
studies, all of which showed no significant 
difference.26–28 Better engagement by 
patients enabled by local design of protocols 
to fit practices’ own populations may have 
aided this finding in this study. Time-series 
analysis of a similar but uncontrolled 
intervention performed in London, showed 
an acceleration in AF prevalence rate during 
the intervention,29 but acceleration seen 
in the control group of the present study 
showed how this can be caused by external 
factors. An earlier randomised controlled 
trial (RCT) did show a significantly higher rate 
of new AF detection within an opportunistic 
screening group.30 It is unclear whether the 
present findings of no statistically significant 
increase in recorded AF prevalence differ 
owing to reduced response to computer 
prompts, reduced effectiveness of pragmatic 
studies, competing external factors, or a 
short-lived effect not detectable at T1 or T2. 
Previously reported clinical effectiveness 
of quality-improvement schemes such as 
QOF in improving measurable outcomes 
has been mixed, for both chronic diseases 
generally and hypertension.5,8–12,15,31–33 
The quality-improvement scheme for AF 
analysed in this article bore similarities 
to a scheme previously used in three 
London primary care trusts, which used 
clinician education, workshops involving 
peer feedback, and computer prompts.34 
In that observational study, time-series 
analysis showed improvements in quality 
measures of management of AF in relation 
to anticoagulation, and by comparison 
with a valid control group; the study by 
the present authors provides evidence that 
improvements demonstrated are likely to 
be due to the intervention itself and not 
the result of external influences. Three 
RCTs in primary care, all in Europe, have 
looked at the use of computer prompts 
alone without any other intervention, and 
only the Swedish study demonstrated any 
statistically significant benefit (P = 0.013).35–37
Implications for research and practice
This study demonstrates that GP 
surgeries can engage in new funded 
quality-improvement schemes that use 
interventions tailored to local needs, 
avoid target-driven payments, and involve 
peer sharing of best practice. Research 
comparing these to existing schemes such 
as QOF are needed to check that effects of 
performance loss seen following removal 
of some other financial incentivised QOF 
targets did not outweigh any benefits of a 
new scheme.38 
Questions are raised by this study about 
the effectiveness of simple opportunistic 
schemes to increase AF diagnosis, 
as recommended by some recent 
commentators.39,40 More research is 
needed to understand which real-world 
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interventions are best placed to increase 
diagnosis rates, and what components or 
incentives may be crucial in facilitating this. 
Initiatives outside of traditional healthcare 
settings such as community health days 
at work, shops, or recreational places 
may yield better results. It is worth noting, 
especially for hypertension, that quality 
of diagnosis does not necessarily equal 
quantity, although overall it does appear 
that it is under diagnosed in north-west 
England.22 The 2011 National Institute of 
Care and Excellence guidelines suggested 
an increased use of home and ambulatory 
BP monitoring to reduce inappropriate 
diagnoses in people who have a ‘white-coat 
effect’41 Future research may wish to look 
at improved specificity of these investigation 
methods in diagnosing hypertension rather 
than viewing any increase in diagnosis rates 
as better, but this was not possible using 
QOF data.
There may be benefits from recording 
new diagnosis rates in the QOF and research 
studies looking at how to avoid effects on 
prevalence of AF and hypertension from 
external factors, such as increasing life 
expectancy and geographical mobility 
(the incidence of changing GP surgeries). 
Future refinement of QOF may ensure that 
measures of chronic disease management 
more fully reflect quality of care. DQAF1 
seems a more accurate way of monitoring 
quality outcomes for the whole population 
of patients with AF than the QOF outcome 
measures AF006 and AF007, which look at 
success among subgroups of patients with 
AF only. With these, interpretation of year-
on-year changes in quality of care is difficult 
— a high previous achievement in AF006 
would decrease the current denominator 
size for AF006, while high achievement in 
AF006 in this or previous years would be 
likely to increase the subgroup denominator 
size for AF007.
Recent views on the impact of financial 
incentives to improve outcomes for patients 
with chronic diseases have tended to 
suggest a move away from payment for 
meeting targets.10,13,42 The present study 
demonstrates that there is potential to 
improve quality of care using an intervention 
without targets, though it may not be 
applicable to all types of chronic disease. 
Further research is needed to understand 
why benefits were shown for quality of 
AF management but not for hypertension 
control. Impact on clinicians’ practices 
may have been bigger for AF than for 
hypertension, as it has been shown that 
clinicians tend to underestimate the 
potential benefit of anticoagulation (for AF) 
and overestimate the risks.43 Education may 
have increased confidence in prescribing 
anticoagulants, whereas skills in treating 
BP had less room for improvement. Surveys 
of clinicians attending workshops may be 
useful to assess whether this is the case.Funding
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